Antonio González

基本信息

浏览量：166

职业迁徙

个人简介

He has participated as principal investigator in over 50 clinical trials and as co-investigator in over 40 clinical trials, mostly on breast and gynecological cancer.
He has also served on the Steering Committee of several clinical trials of which PRIMA and PAOLA-1 are currently active.
In addition, he has worked as a collaborating researcher in several funded research projects.
Dr. González is the president of the Spanish Ovarian Cancer Group (GEICO), a scientific association for clinical and translational research in gynecological cancer and especially ovarian cancer.
He is also GEICO's representative in the European Network for Gynecological Oncologycal Trials (ENGOT) and the Gynecologic Cancer InterGroup (GCIG); an international organisation for clinical trials and treatment of gynecological cancers, where he is currently the chairman of the ovarian cancer committee.

研究兴趣

论文共 406 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or Without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study)

Beatriz Tavira,Teresa Iscar,Luis Manso,Ana Santaballa,Marta Gil-Martin, Garcia,Margarita Romeo,Maria Iglesias,Ana de Juan Ferre,Maria Pilar Barretina-Ginesta,Aranzazu Manzano,Lydia Gaba,Maria Jesus Rubio,Carlos E. de Andrea,Antonio Gonzalez-Martin

CLINICAL CANCER RESEARCHno. 1 (2024): 176-186

引用0浏览0WOS引用

Tolerability of the Niraparib Individualized Starting Dose in the PRIMA/ENGOT-OV26/GOG-3012 Trial of Niraparib First-Line Maintenance Therapy

Christof Vulsteke,Setsuko K. Chambers,Maria Jesus Rubio Perez,John K. Chan, Nicoline Raaschou-Jensen, Ying Zhuo,Domenica Lorusso,Thomas J. Herzog,Thibault de la Motte Rouge, Jessica A. Thomes Pepin,Elena Ioana Braicu,Lee-may Chen,Tally Levy,James F. Barter, M. Pilar Barretina-Ginesta,Eric Joosens,Whitney York,Izabela A. Malinowska,Antonio Gonzalez-Martin,Bradley J. Monk

EUROPEAN JOURNAL OF CANCER (2024)

引用0浏览0WOS引用

Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Expressing Solid Tumors: Primary Results from the DESTINY-PanTumor02 Phase II Trial

Funda Meric-Bernstam,Vicky Makker,Ana Oaknin,Do-Youn Oh,Susana Banerjee,Antonio Gonzalez-Martin,Kyung Hae Jung,Iwona Lugowska,Luis Manso,Aranzazu Manzano,Bohuslav Melichar,Salvatore Siena,Daniil Stroyakovskiy,Anitra Fielding, Yan Ma,Soham Puvvada,Norah Shire,Jung-Yun Lee

JOURNAL OF CLINICAL ONCOLOGYno. 1 (2024): 47-+

引用0浏览0WOS引用

237 InnovaTV 301/Engot-Cx12/gog-3057: a Global, Randomized, Open-Label, Phase 3 Study of Tisotumab Vedotin Versus Investigator’s Choice of Chemotherapy in 2L or 3L Recurrent or Metastatic Cervical Cancer

Antonio González Martín,Brian M. Slomovitz,Keiichi Fujiwara,Elsa Kalbacher, Andrea Bagaméri,Sharad Ghamande,Jung‐Yun Lee,Susana Banerjee,Fernando C. Maluf,Domenica Lorusso,Kan Yonemori,Els Van Nieuwenhuysen,Luis Manso,Linn Woelber,Anneke M. Westermann,Allan Covens, Elizabeth Whalley, Melinda Siew Leng Teng,Ibrahima Soumaoro,Ignace Vergote

openalex（2024）

引用0浏览0引用

An International Worldwide Retrospective Cohort Observational Study Comparing Primary Cytoreductive Surgery with Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Patients with Carcinoma of the Ovary, Fallopian Tubes, and Peritoneum (SUROVA Trial)

Luis Chiva, Pilar Ordas,Nerea Martin-Calvo,Jose Manuel Aramendia,Luisa Sanchez Lorenzo,Alejandro Gallego Martinez, Angel Vizcay,Jose Angel Minguez,Nabil Manzour,Daniel Vazquez-Vicente,Enrique Chacon,Teresa Castellanos,Antonio Gonzalez Martin

International journal of gynecological cancerpp.ijgc-005354, (2024)

引用0浏览0WOS引用

Phase II Dose Optimization with EZH2/EZH1 Inhibitor Tulmimetostat in Patients (pts) with Advanced Solid Tumors or Hematologic Malignancies

Ana Oaknin,Kalyan Banda,Charles Drescher,Vincent Ribrag, Hedy L. Kindler,Harriet S. Walter,Alok Tewari,Elvire Pons-Tostivint,Nehal J. Lakhani,R. Donald Harvey,Ryan J. Sullivan,Pier Luigi Zinzani,Antonio Gonzalez Martin,Lauriane Eberst, Luis Manso Sanchez,Anjali Thakur, Lennart Kann, Archana Reddy,Nicola Faulhaber,Linda Duska

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

A plain language summary of publication of the efficacy and safety of individualized niraparib dosing based on baseline body weight and platelet count in the PRIMA/ENGOT-OV26/GOG-3012 trial

Future oncology (London, England)no. 13 (2024): 799-809

引用0浏览0WOS引用

SENECA Study: Staging Endometrial Cancer Based on Molecular Classification

Enrique Chacon,Felix Boria, R. Rajagopalan Lyer, Francesco Fanfani, Mario Malzoni, Petra Bretova, Ana Luzarraga Aznar, Robert Fruscio, Marcin A. Jedryka, Richard Toth, Anna Myriam Perrone,Athanasios Kakkos, Ignacio Cristobal Quevedo, Luigi Congedo,Vanna Zanagnolo, Sergi Fernandez-Gonzalez, Beatriz Ferro, Fabrice Narducci, Tatevik Hovhannisyan, Elif Aksahin, Laura Cardenas, M. Reyes Oliver, Gonzalo Nozaleda, Marta Arnaez,Marcin Misiek, Annamaria Ferrero, Flore Anne Pain, Janire Zarragoitia, Cristina Diaz, Lorenzo Ceppi, Shamsi Mehdiyev, Fernando Roldan-Rivas, Alberto Rafael Guijarro-Campillo, Joana Amengual, Nabil Manzour,Luisa Sanchez Lorenzo, Jorge M. Nunez-Cordoba,Antonio Gonzalez Martin,Jose Angel Minguez,Luis Chiva

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2024)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

副教授

论文共 406 篇作者统计合作学者相似作者